LPL Financial
VRTX icon

LPL Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

LPL Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-500
Closed -$242K – 5696
2025
Q1 		$242K Buy
+500
New +$233K ﹤0.01% 4724
2024
Q1 		– Sell
-3,000
Closed -$1.22M – 5036
2023
Q4 		$1.22M Buy
+3,000
New +$1.11M ﹤0.01% 2880

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

LPL Financial's VRTX Position: Q1 2026 in Review

LPL Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q1 2026, selling an estimated $4.11M and leaving 268,062 shares worth $120M. The position accounts for 0.03% of the portfolio, ranked #512.

LPL Financial first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $126M in Q4 2025. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • LPL Financial held 268,062 shares of Vertex Pharmaceuticals worth $120M as of Q1 2026.
  • LPL Financial sold 8,816 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.11M.
  • Vertex Pharmaceuticals made up 0.03% of LPL Financial's portfolio in Q1 2026, its #512 holding.
  • LPL Financial first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's Vertex Pharmaceuticals position peaked at $126M in Q4 2025.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.